Koeberl, D., Kishnani, P., Goldenberg, P., Dearmey, S., Heller, J., Benjamin, D., … Chen, Y.-T. (2009). 77. Cross-reacting immunologic material status affects outcomes in infants with Pompe disease treated with alglucosidase alfa. Molecular Genetics and Metabolism, 96(2), S28–S29. https://doi.org/10.1016/j.ymgme.2008.11.078

Koeberl, Dwight, Priya Kishnani, Paula Goldenberg, Stephanie Dearmey, James Heller, Danny Benjamin, Sarah Young, et al. “77. Cross-reacting immunologic material status affects outcomes in infants with Pompe disease treated with alglucosidase alfa.” Molecular Genetics and Metabolism 96, no. 2 (February 2009): S28–29. https://doi.org/10.1016/j.ymgme.2008.11.078.

Koeberl D, Kishnani P, Goldenberg P, Dearmey S, Heller J, Benjamin D, et al. 77. Cross-reacting immunologic material status affects outcomes in infants with Pompe disease treated with alglucosidase alfa. Molecular Genetics and Metabolism. 2009 Feb;96(2):S28–9.

Koeberl, Dwight, et al. “77. Cross-reacting immunologic material status affects outcomes in infants with Pompe disease treated with alglucosidase alfa.” Molecular Genetics and Metabolism, vol. 96, no. 2, Elsevier BV, Feb. 2009, pp. S28–29. Crossref, doi:10.1016/j.ymgme.2008.11.078.

Koeberl D, Kishnani P, Goldenberg P, Dearmey S, Heller J, Benjamin D, Young S, Bali D, Smith SA, Li J, Mandel H, Rosenburg A, Chen Y-T. 77. Cross-reacting immunologic material status affects outcomes in infants with Pompe disease treated with alglucosidase alfa. Molecular Genetics and Metabolism. Elsevier BV; 2009 Feb;96(2):S28–S29.